Gynecologic Cancer
Conference Coverage
Endometrial thickness could predict cancer, guide lymph node assessment
Patients with endometrial intraepithelial neoplasia don’t need routine lymph node sampling, an investigator says.
Commentary
How physicians can provide better care to transgender patients
Those transgender patients who seek care often have unpleasant experiences.
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Feature
Cancer screening stopped by pandemic: Repercussions to come?
From the Journals
Frailty screening should be routine in endometrial cancer surgery
Conference Coverage
Study supports lower starting dose of lenvatinib for endometrial cancer
A 14-mg dose was safer and just as effective as a 20-mg dose in a retrospective study.
Conference Coverage
Combo shows efficacy in platinum-resistant ovarian cancer
Ixabepilone plus bevacizumab improved outcomes, compared with ixabepilone alone.
From the Journals
Call to eradicate all types of HPV cancers, not just cervical
"I completely agree that our ultimate goal should be the elimination of all HPV-related cancers - but we will require gender-neutral vaccination...
Conference Coverage
Niraparib maintenance offers continued benefit in some with recurrent ovarian cancer
Benefits were seen in patients with germline BRCA mutations.
Conference Coverage
Biomarkers predict efficacy of DKN-01 in endometrial cancer
High levels of DKK1 expression and the presence of Wnt or PIK3CA activating mutations are associated with better outcomes.
Opinion
The significance of mismatch repair deficiency in endometrial cancer
Endometrial cancers can be tested for MMR-d by performing immunohistochemistry to look for loss of expression in the four most common MMR genes,...